World Courier quadruples size of its Buenos Aires clinical trial logistics depot
Major expansions in Argentina and Singapore point to heightened biopharma focus on emerging markets
Following its planned acquisition by AmerisourceBergen, World Courier (Stamford, CT) is getting more public about its recent internal investments. The company is currently undergoing audits of a new Buenos Aires, Argentina depot that quadruples the size of existing facilities there, to 37,000 sq. ft. The facility is expected to be fully operational next month. “Customer demand for clinical trial storage in Argentina and throughout Latin America continues to remain very strong,” said Carlos Jankowski, global executive director for the company’s Clinical Trial Supply Chain Services Division.
In recent months, World Courier has also expanded its Singapore facility to 135,000 sq.ft., making it the largest of the company’s 13 facilities around the world. Other facilities have expanded, or are in the process of being upgraded, in Sao Paulo, Santiago, Beijing, Bogota, Bengaluru (India), Mexico City, Lima, Moscow and Johannesburg. All these facilities are said to incorporate GMP-compliant processes, have validated storage for controlled ambient, refrigerated, frozen and deep-frozen storage, and are staffed with licensed pharmacists. Around this infrastructure, the company wraps an additional 137 ISO 9001-certified offices in 52 countries, and says that it is currently handling projects for 500 biopharma companies worldwide.
LogiPharma Unpacked: Highlights, Key Insights, and the Road to 2025
October 16th 2024In this special post-show episode, we sit down with Ryan Portela, Head of Production for LogiPharma, to reflect on the highlights and key takeaways from this year’s event. From attendee feedback to the most impactful sessions, Ryan shares insider insights and discusses how the momentum from 2024 will continue to shape the future of pharma supply chains. Plus, get a sneak peek into the exciting plans for LogiPharma's 20th Anniversary in 2025.
Reimagining Closed-Loop Marketing Strategies for Pharma Companies
November 21st 2024The pharmaceutical industry is evolving, and so are the strategies needed to connect with healthcare professionals. Closed-loop marketing (CLM) has become essential in delivering personalized, data-driven engagement that resonates with physicians and improves key outcomes, such as enhancing patient care, increasing
Maximize Pharma’s Potential with AI-Ready Data for Commercial Excellence
November 21st 2024As the pharmaceutical industry embraces the power of AI, having data that’s large, diverse, and well-structured is critical for driving innovation and improving outcomes. Ensuring your data is AI-ready and can be used with more advanced solutions enables your teams to make informed strategic decisions, predict trends, enhance customer engagements and drive overall strategy.
